Dr. Bhavesh Poladia
DNB, DM.
Senior Consultant
- Jan 2004 to Dec 2004 – Grant Medical College & Sir J.J. Group of Hospitals, Mumbai.
- August 2006 to July 2010 – General Medicine department in Lilavati Hospital and Research Centre, Mumbai.
- August 2010 To July 2016 – Medical Oncology department in Tata Memorial Hospital (TMH), Mumbai.
September 2016 till date – Thangam Hospital and Thangam Cancer Centre, Namakkal, Tamilnadu.
- 2015 – Homi Bhabha National Institute, DM Medical Oncology, Tata Memorial Hospital (TMH), Mumbai.
- 2010 – National Board of Examination – DNB General Medicine, Lilavati Hospital and Research Centre, Mumbai.
- 2003 – Grant Medical College & Sir J.J.Group of Hospitals, Mumbai.
- As a contributing author in ‘Practice patterns and outcomes with the use of regorafenib in metastatic colorectal cancer: Results from the Regorafenib in Metastatic colorectal cancer – An Indian exploratory analysis study’ South Asian Journal of Cancer, January 2019.
- As a contributing author in ‘Docetaxel/Oxaliplatin/Capecitabine (TEX) triplet followed by continuation monotherapy in advanced gastric cancer’ Indian Journal of Cancer, January 2018.
- As a contributing author in ‘Outcome of metastatic neuroendocrine tumors with Cap-Tem regimen: A retrospective tertiary care center analysis’ Digestive Surgery, January 2016.
- As a contributing author in ‘Retrospective Analysis of Prospective Database Assessing the Efficacy and Tolerability of First Line Docetaxel Based Chemotherapy Followed by Docetaxel or Capecitabine Maintenance in Non-progressive, Metastatic stomach adenocarcinoma-Experience from tertiary referral centre’ Digestive Surgery, January 2016.
- As a first author in ‘Development of hyponatremia on neoadjuvant chemotherapy in locally advanced head & neck cancers’ Conference Paper in ESMO, January 2013.
- As a contributing author in ‘Epidemiology of oral cancers referred for NACT, the demographics, clinical profile, and organ functions’ Conference Paper in ASCO, January 2013.
- As a contributing author in ‘Induction Chemotherapy in Locally Advanced Pharyngolaryngeal Cancers with Stridor: Is It Feasible and Safe?’ Chemotherapy Research and Practice, August 2012.
- As a contributing author in ‘Unusual coexistence of renal anomaly and germ cell tumour: An embryonal happenstance?’ Indian Journal of Medical and Paediatric Oncology, July 2012.
- As a second author in ‘Hyperammonemic Coma Presenting as Hashimoto’s Encephalopathy’ Journal of the Association of Physicians of India, October 2008.
Practice
- Jan 2004 to Dec 2004 – Grant Medical College & Sir J.J. Group of Hospitals, Mumbai.
- August 2006 to July 2010 – General Medicine department in Lilavati Hospital and Research Centre, Mumbai.
- August 2010 To July 2016 – Medical Oncology department in Tata Memorial Hospital (TMH), Mumbai.
- September 2016 till date – Thangam Hospital and Thangam Cancer Centre, Namakkal, Tamilnadu.
Education & Training
- 2015 – Homi Bhabha National Institute, DM Medical Oncology, Tata Memorial Hospital (TMH), Mumbai.
- 2010 – National Board of Examination – DNB General Medicine, Lilavati Hospital and Research Centre, Mumbai.
- 2003 – Grant Medical College & Sir J.J.Group of Hospitals, Mumbai.
Publications
- As a contributing author in ‘Practice patterns and outcomes with the use of regorafenib in metastatic colorectal cancer: Results from the Regorafenib in Metastatic colorectal cancer – An Indian exploratory analysis study’ South Asian Journal of Cancer, January 2019.
- As a contributing author in ‘Docetaxel/Oxaliplatin/Capecitabine (TEX) triplet followed by continuation monotherapy in advanced gastric cancer’ Indian Journal of Cancer, January 2018.
- As a contributing author in ‘Outcome of metastatic neuroendocrine tumors with Cap-Tem regimen: A retrospective tertiary care center analysis’ Digestive Surgery, January 2016.
- As a contributing author in ‘Retrospective Analysis of Prospective Database Assessing the Efficacy and Tolerability of First Line Docetaxel Based Chemotherapy Followed by Docetaxel or Capecitabine Maintenance in Non-progressive, Metastatic stomach adenocarcinoma-Experience from tertiary referral centre’ Digestive Surgery, January 2016.
- As a first author in ‘Development of hyponatremia on neoadjuvant chemotherapy in locally advanced head & neck cancers’ Conference Paper in ESMO, January 2013.
- As a contributing author in ‘Epidemiology of oral cancers referred for NACT, the demographics, clinical profile, and organ functions’ Conference Paper in ASCO, January 2013.
- As a contributing author in ‘Induction Chemotherapy in Locally Advanced Pharyngolaryngeal Cancers with Stridor: Is It Feasible and Safe?’ Chemotherapy Research and Practice, August 2012.
- As a contributing author in ‘Unusual coexistence of renal anomaly and germ cell tumour: An embryonal happenstance?’ Indian Journal of Medical and Paediatric Oncology, July 2012.
- As a second author in ‘Hyperammonemic Coma Presenting as Hashimoto’s Encephalopathy’ Journal of the Association of Physicians of India, October 2008.